Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
23.00
-0.37 (-1.58%)
Apr 28, 2026, 4:00 PM EDT - Market closed
AAPG Employees
Ascentage Pharma Group International had 767 employees as of December 31, 2025. The number of employees increased by 200 or 35.27% compared to the previous year.
Employees
767
Change (1Y)
200
Growth (1Y)
35.27%
Revenue / Employee
$107,018
Profits / Employee
-$231,657
Market Cap
2.16B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Sarepta Therapeutics | 835 |
| Adaptive Biotechnologies | 624 |
| Ocular Therapeutix | 325 |
| Zymeworks | 264 |
| Capricor Therapeutics | 231 |
| Aurinia Pharmaceuticals | 128 |
| Definium Therapeutics | 106 |
AAPG News
- 6 days ago - Ascentage Pharma to Present Data from Multiple Trials, Including Three Rapid Oral Presentations, at ASCO 2026 - GlobeNewsWire
- 8 days ago - Ascentage Pharma to Present Four Promising Preclinical Studies Demonstrating the Potential of Combination Therapies at American Association for Cancer Research (AACR) 2026 Annual Meeting - GlobeNewsWire
- 4 weeks ago - Full Year 2025 Ascentage Pharma Group International Earnings Presentation Transcript - GuruFocus
- 4 weeks ago - Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates - GlobeNewsWire
- 5 weeks ago - Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026 - GlobeNewsWire
- 6 weeks ago - Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026 - GlobeNewsWire
- 2 months ago - Ascentage Pharma Group International is Now Oversold (AAPG) - Nasdaq
- 2 months ago - Ascentage Pharma Announces IND Clearance by the China CDE for BTK Degrader APG-3288 - GlobeNewsWire